...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >NK Cells Infiltrating a MHC Class I-Deficient Lung Adenocarcinoma Display Impaired Cytotoxic Activity toward Autologous Tumor Cells Associated with Altered NK Cell-Triggering Receptors.
【24h】

NK Cells Infiltrating a MHC Class I-Deficient Lung Adenocarcinoma Display Impaired Cytotoxic Activity toward Autologous Tumor Cells Associated with Altered NK Cell-Triggering Receptors.

机译:浸润MHC I类缺陷的肺腺癌的NK细胞对与改变的NK细胞触发受体相关的自体肿瘤细胞显示出受损的细胞毒活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

NK cells are able to discriminate between normal cells and cells that have lost MHC class I (MHC-I) molecule expression as a result of tumor transformation. This function is the outcome of the capacity of inhibitory NK receptors to block cytotoxicity upon interaction with their MHC-I ligands expressed on target cells. To investigate the role of human NK cells and their various receptors in the control of MHC-I-deficient tumors, we have isolated several NK cell clones from lymphocytes infiltrating an adenocarcinoma lacking beta(2)-microglobulin expression. Unexpectedly, although these clones expressed NKG2D and mediated a strong cytolytic activity toward K562, Daudi and allogeneic MHC-class I(+) carcinoma cells, they were unable to lyse the autologous MHC-I(-) tumor cell line. This defect was associated with alterations in the expression of natural cytotoxicity receptor (NCR) by NK cells and the NKG2D ligands, MHC-I-related chain A, MHC-I-related chain B, and UL16 binding protein 1, and the ICAM-1 by tumor cells. In contrast, the carcinoma cell line was partially sensitive to allogeneic healthy donor NK cells expressing high levels of NCR. Indeed, this lysis was inhibited by anti-NCR and anti-NKG2D mAbs, suggesting that both receptors are required for the induced killing. The present study indicates that the MHC-I-deficient lung adenocarcinoma had developed mechanisms of escape from the innate immune response based on down-regulation of NCR and ligands required for target cell recognition.
机译:NK细胞能够区分正常细胞和由于肿瘤转化而失去I类MHC(MHC-1)分子表达的细胞。此功能是抑制性NK受体与靶细胞上表达的MHC-1配体相互作用后阻断细胞毒性的能力的结果。为了研究人类NK细胞及其各种受体在控制MHC-1缺陷型肿瘤中的作用,我们从浸润缺乏β(2)-微球蛋白表达的腺癌的淋巴细胞中分离了几个NK细胞克隆。出乎意料的是,尽管这些克隆表达NKG2D并介导了对K562,Daudi和同种MHC-Class I(+)癌细胞的强溶细胞活性,但它们无法裂解自体MHC-I(-)肿瘤细胞系。此缺陷与NK细胞和NKG2D配体,MHC-1相关链A,MHC-1相关链B和UL16结合蛋白1以及ICAM-N的天然细胞毒性受体(NCR)表达的改变有关。 1由肿瘤细胞组成。相反,癌细胞系对表达高水平NCR的同种异体健康供体NK细胞部分敏感。实际上,该裂解被抗NCR和抗NKG2D mAb抑制,表明诱导杀伤需要两个受体。本研究表明,基于下调NCR和靶细胞识别所需的配体,MHC-1缺陷型肺腺癌已发展出逃避先天免疫应答的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号